Natural Health Farm Holdings Inc. (NHEL) Stock Price & Analysis
Educational signal · not a buy or sell recommendation · How to read this
For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated Mar 18, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Quick AnswerNatural Health Farm Holdings Inc. (NHEL) trades at $0.0001. Natural Health Farm Holdings Inc. is a development stage biotechnology company focused on creating a healthcare ecosystem based on natural products. Sector: Healthcare.
Price as of · Last analyzed: Mar 18, 2026Analyst Coverage for NHEL: NHEL does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage.
No score published: we hold no usable price for this ticker, and a grade beside a missing price says nothing.
Natural Health Farm Holdings Inc. (NHEL) Healthcare & Pipeline Overview
Natural Health Farm Holdings Inc., a development-stage biotechnology company based in Malaysia, focuses on developing a healthcare ecosystem centered around natural and naturopathic products. Trading on the OTC market, the company aims to leverage natural health solutions within the healthcare sector, facing challenges typical of early-stage biotech ventures.
What Is the Investment Thesis for NHEL?
Investing in Natural Health Farm Holdings Inc. presents a high-risk, high-reward scenario typical of development-stage biotechnology companies. The company's focus on natural health products aligns with growing consumer demand for alternative healthcare solutions. However, the company's negative profit margin of -36.6% and ROE of -32.1% indicate significant financial challenges. Key value drivers include successful development and commercialization of its product pipeline, securing regulatory approvals, and expanding its market presence. The company's high beta of -93.23 suggests extreme volatility compared to the market. Investors should carefully consider the risks associated with investing in an OTC-listed, development-stage company with limited financial resources.
Based on FMP financials and quantitative analysis
NHEL Key Highlights
Market capitalization of $0.00B indicates a micro-cap company with limited financial resources.
- Gross margin of 68.6% suggests potential for profitability if sales volume increases.
- Negative profit margin of -36.6% reflects ongoing losses and the need for significant revenue growth.
- Debt-to-equity ratio of 29.57 indicates moderate leverage.
- Negative ROE of -32.1% highlights the company's inefficiency in generating profits from equity.
Who Are NHEL's Competitors?
NHEL is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | MoonshotScore |
|---|---|---|---|---|
| SCNX Scienture Holdings, Inc. | $3.72 | -6.34% | $6.45M | — |
| ACON Aclarion, Inc. | $2.36 | -0.84% | $6.86M | — |
| MGRX Mangoceuticals, Inc. | $0.43 | -0.50% | $7.42M | — |
| BFRG Bullfrog AI Holdings, Inc. Common Stock | $0.62 | +0.84% | $11.5M | — |
| ONMD OneMedNet Corporation | $5.52 | +2.41% | $30.7M | — |
| EUDA EUDA Health Holdings Limited | $17.63 | +2.28% | $32.5M | — |
| BEAT HeartBeam, Inc. | $0.70 | +61.71% | $38.7M | — |
| CCLD CareCloud, Inc. | $2.06 | +2.23% | $87.5M | 68 5-pillar |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are NHEL's Key Strengths?
Focus on natural health products aligns with consumer trends.
- Proprietary formulations and research.
- Potential for high gross margins.
- Experienced management team.
What Are NHEL's Weaknesses?
Development stage company with limited financial resources.
- Negative profit margin and ROE.
- OTC listing increases risk and volatility.
- Limited market presence and brand recognition.
What Are the Key Risks for NHEL?
Financial-distress signal — its Altman Z-Score of -0.13 sits in the distress zone (elevated bankruptcy risk).
- Weak fundamentals — a Piotroski F-Score of 2/9 flags soft profitability, leverage or efficiency.
- Limited financial resources and negative profitability.
- Regulatory challenges and compliance costs.
- Competition from established healthcare companies.
- Market acceptance of alternative therapies.
- OTC listing and associated risks.
What Are NHEL's Competitive Advantages?
- Focus on natural and naturopathic products.
- Proprietary formulations and research.
- Strategic partnerships within the healthcare industry.
- Brand reputation and customer loyalty.
What Does NHEL Do?
Natural Health Farm Holdings Inc., established in 2014 and headquartered in Rawang, Malaysia, is a biotechnology company in the development stage. The company is focused on creating a healthcare ecosystem based on natural and naturopathic products. Formerly known as Amber Group, Inc., the company rebranded to Natural Health Farm Holdings Inc. in March 2017, signaling a strategic shift towards natural health solutions. As a development stage company, Natural Health Farm Holdings Inc. is currently focused on research and development of its product offerings. The company's focus on natural products aligns with growing consumer interest in alternative and complementary medicine. However, as an OTC-listed company with a small market capitalization, Natural Health Farm Holdings Inc. faces challenges related to funding, regulatory approvals, and market acceptance. The company's success will depend on its ability to successfully develop and commercialize its natural health products and navigate the competitive healthcare landscape.
What Products and Services Does NHEL Offer?
- Develops healthcare eco-systems based on natural products.
- Focuses on biotechnology research and development.
- Aims to create alternative healthcare solutions.
- Markets and distributes natural health products.
- Conducts research on naturopathic remedies.
- Seeks regulatory approvals for its products.
- Forms strategic partnerships within the healthcare industry.
How Does NHEL Make Money?
- Develops and commercializes natural health products.
- Generates revenue through product sales.
- Partners with distributors and retailers.
- Invests in research and development to create new products.
What Industry Does NHEL Operate In?
Natural Health Farm Holdings Inc. operates in the healthcare information services industry, which is experiencing growth driven by increasing demand for personalized medicine and digital health solutions. The market is competitive, with established players like McKesson Corporation and Cerner Corporation, as well as emerging companies focused on niche areas such as telehealth and remote patient monitoring. Natural Health Farm Holdings Inc.'s focus on natural health products differentiates it from traditional healthcare providers, but it also faces challenges related to regulatory scrutiny and market acceptance of alternative therapies.
Who Are NHEL's Key Customers?
- Individuals seeking natural health solutions.
- Healthcare providers interested in alternative therapies.
- Retailers and distributors of health products.
- Wellness centers and complementary medicine clinics.
Research confidence
Thin evidence — scoring coverage unknown. Treat this as a starting point, not a conclusion.
- ● Scoring coverage unknown
- ● No usable price
- ● No filing on record
- ● No analyst coverage
Company Profile
Natural Health Farm Holdings Inc. operates in the Medical - Healthcare Information Services industry within the Healthcare sector. It is headquartered in Rawang, MY. The company is led by CEO Chuen Meng Tee. NHEL has traded publicly since 2018.
Financial Health
Natural Health Farm Holdings Inc.'s Piotroski F-Score is 2/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny. Its Altman Z-Score of -0.13 places it in the distress zone, a signal of elevated financial risk.
NHEL Financials
NHEL Latest News
No recent news available for NHEL.
NHEL Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations collected by Financial Modeling Prep for NHEL.
Price Targets
Wall Street price target analysis for NHEL.
NHEL MoonshotScore
MoonshotScore is Stock Expert AI's proprietary 0-100 research rating, not a buy or sell recommendation. No MoonshotScore is published for NHEL; grades run from A+ (80-100) to F (below 30).
Leadership: Chuen Meng Tee
CEO
Chuen Meng Tee serves as the Chief Executive Officer of Natural Health Farm Holdings Inc. His background includes experience in business development and strategic planning within the healthcare sector. He has a proven track record of leading teams and driving growth in emerging markets. Mr. Tee holds a degree in Business Administration and has completed executive education programs focused on leadership and innovation.
Track Record: Since assuming the role of CEO, Chuen Meng Tee has focused on repositioning the company towards natural health solutions and securing strategic partnerships. He has overseen the rebranding of the company and the development of its initial product pipeline. His leadership has been instrumental in navigating the challenges of operating as a development-stage company in a competitive industry.
NHEL OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that Natural Health Farm Holdings Inc. may not meet the minimum financial standards or reporting requirements of higher tiers like OTCQX or OTCQB. Companies in this tier may have limited financial disclosures and may not be subject to the same level of regulatory oversight as companies listed on major exchanges like the NYSE or NASDAQ. Investing in OTC Other stocks carries significant risks due to the potential for fraud, lack of transparency, and limited liquidity.
- OTC Tier: OTC Other
- Limited financial disclosures and transparency.
- Potential for fraud and manipulation.
- High price volatility and illiquidity.
- Lack of regulatory oversight and investor protection.
- Going concern risk due to limited financial resources.
- Verify the company's legal status and registration.
- Review available financial statements and disclosures.
- Assess the company's management team and track record.
- Evaluate the company's business model and competitive landscape.
- Understand the risks associated with investing in OTC stocks.
- Consult with a qualified financial advisor.
- Check for any regulatory actions or legal proceedings.
- Company registration and legal compliance.
- Presence of a management team and board of directors.
- Focus on developing natural health products.
- Strategic partnerships within the healthcare industry.
- Efforts to secure regulatory approvals.
What Investors Ask About Natural Health Farm Holdings Inc. (NHEL) — Healthcare
What do analysts say about NHEL stock?
As of March 18, 2026, there is limited analyst coverage of Natural Health Farm Holdings Inc. due to its OTC listing and small market capitalization.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
MoonshotScore is not published for this security.
Data provided for informational purposes only.
- Limited information available on the company due to its OTC listing and development stage.
- Financial data may not be fully reliable due to limited disclosures.